PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction
Oncogene, Published online: 07 August 2023; doi:10.1038/s41388-023-02785-5PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction (Source: Oncogene)
Source: Oncogene - August 7, 2023 Category: Cancer & Oncology Authors: Upasana Ray Prabhu Thirusangu Ling Jin Yinan Xiao Christopher L. Pathoulas Julie Staub Courtney L. Erskine Keith Dredge Edward Hammond Matthew S. Block Scott H. Kaufmann Jamie N. Bakkum-Gamez Viji Shridhar Source Type: research

Therapeutic targeting of FUBP3 phase separation by GATA2-AS1 inhibits malate-aspartate shuttle and neuroblastoma progression via modulating SUZ12 activity
Oncogene, Published online: 03 August 2023; doi:10.1038/s41388-023-02798-0Therapeutic targeting of FUBP3 phase separation by GATA2-AS1 inhibits malate-aspartate shuttle and neuroblastoma progression via modulating SUZ12 activity (Source: Oncogene)
Source: Oncogene - August 3, 2023 Category: Cancer & Oncology Authors: Xiaojing Wang Yanhua Guo Guo Chen Erhu Fang Jianqun Wang Qilan Li Dan Li Anpei Hu Banghe Bao Yi Zhou Haiyang Gao Jiyu Song Xinyi Du Liduan Zheng Qiangsong Tong Source Type: research

The DUBA-SLC7A11-c-Myc axis is critical for stemness and ferroptosis
Oncogene, Published online: 03 August 2023; doi:10.1038/s41388-023-02744-0The DUBA-SLC7A11-c-Myc axis is critical for stemness and ferroptosis (Source: Oncogene)
Source: Oncogene - August 3, 2023 Category: Cancer & Oncology Authors: Zuli Wang Lianlian Ouyang Na Liu Tiansheng Li Bokang Yan Chao Mao Desheng Xiao Boyi Gan Shuang Liu Yongguang Tao Source Type: research

Retraction Note: p14ARF promotes RB accumulation through inhibition of its Tip60-dependent acetylation
Oncogene, Published online: 31 July 2023; doi:10.1038/s41388-023-02789-1Retraction Note: p14ARF promotes RB accumulation through inhibition of its Tip60-dependent acetylation (Source: Oncogene)
Source: Oncogene - July 31, 2023 Category: Cancer & Oncology Authors: C. Leduc P. Claverie B. Eymin E. Col S. Khochbin E. Brambilla S. Gazzeri Source Type: research

Retraction Note: Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC
Oncogene, Published online: 31 July 2023; doi:10.1038/s41388-023-02790-8Retraction Note: Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC (Source: Oncogene)
Source: Oncogene - July 31, 2023 Category: Cancer & Oncology Authors: Boya Zhang Mingpeng Zhang Yanjie Yang Qi Li Jianpeng Yu Shimiao Zhu Yuanjie Niu Zhiqun Shang Source Type: research

Microenvironmental Snail1-induced immunosuppression promotes melanoma growth
Oncogene, Published online: 29 July 2023; doi:10.1038/s41388-023-02793-5Microenvironmental Snail1-induced immunosuppression promotes melanoma growth (Source: Oncogene)
Source: Oncogene - July 29, 2023 Category: Cancer & Oncology Authors: Marta Arumi-Planas Francisco Javier Rodriguez-Baena Francisco Cabello-Torres Francisco Gracia Cristina Lopez-Blau M. Angela Nieto Berta Sanchez-Laorden Source Type: research

Retraction Note: YAP1-induced MALAT1 promotes epithelial–mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer
Oncogene, Published online: 28 July 2023; doi:10.1038/s41388-023-02794-4Retraction Note: YAP1-induced MALAT1 promotes epithelial–mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer (Source: Oncogene)
Source: Oncogene - July 28, 2023 Category: Cancer & Oncology Authors: Zhenqiang Sun Chunlin Ou Jinbo Liu Chen Chen Quanbo Zhou Shuaixi Yang Guiyuan Li Guixian Wang Junmin Song Zhen Li Zhiyong Zhang Weitang Yuan Xiayu Li Source Type: research

Activation of NFAT by HGF and IGF-1 via ARF6 and its effector ASAP1 promotes uveal melanoma metastasis
Oncogene, Published online: 27 July 2023; doi:10.1038/s41388-023-02792-6Activation of NFAT by HGF and IGF-1 via ARF6 and its effector ASAP1 promotes uveal melanoma metastasis (Source: Oncogene)
Source: Oncogene - July 27, 2023 Category: Cancer & Oncology Authors: Jackson R. Richards Donghan Shin Rob Pryor Lise K. Sorensen Zhonglou Sun Won Mi So Garam Park Roger Wolff Amanda Truong Martin McMahon Allie H. Grossmann J. William Harbour Weiquan Zhu Shannon J. Odelberg Jae Hyuk Yoo Source Type: research

A novel transcription factor SIPA1: identification and verification in triple-negative breast cancer
Oncogene, Published online: 27 July 2023; doi:10.1038/s41388-023-02787-3A novel transcription factor SIPA1: identification and verification in triple-negative breast cancer (Source: Oncogene)
Source: Oncogene - July 27, 2023 Category: Cancer & Oncology Authors: Lijuan Guo Wanjun Zhang Xue Zhang Jun Wang Jiaqi Nie Xiaomeng Jin Ying Ma Shi Wang Xinhong Zhou Yilei Zhang Yan Xu Yoshimasa Tanaka Jingping Yuan Xing-Hua Liao Yiping Gong Li Su Source Type: research

A HUWE1 defect causes PARP inhibitor resistance by modulating the BRCA1-∆11q splice variant
Oncogene, Published online: 25 July 2023; doi:10.1038/s41388-023-02782-8A HUWE1 defect causes PARP inhibitor resistance by modulating the BRCA1-∆11q splice variant (Source: Oncogene)
Source: Oncogene - July 25, 2023 Category: Cancer & Oncology Authors: Stephen J. Pettitt Nan Shao Diana Zatreanu Jessica Frankum Ilirjana Bajrami Rachel Brough Dragomir B. Krastev Theodoros I. Roumeliotis Jyoti S. Choudhary Sonja Lorenz Alistair Rust Johann S. de Bono Timothy A. Yap Andrew N. J. Tutt Christopher J. Lord Source Type: research

Correction to: PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3
Oncogene, Published online: 25 July 2023; doi:10.1038/s41388-023-02735-1Correction to: PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3 (Source: Oncogene)
Source: Oncogene - July 25, 2023 Category: Cancer & Oncology Authors: Qian-Wen Zheng Qian-Zhi Ni Bing Zhu Xin Liang Ning Ma Yi-Kang Wang Sheng Xu Hui-Jun Cao Ji Xia Feng-Kun Zhang Er-Bin Zhang Xiao-Song Qiu Xu-Fen Ding Lin Qiu Xi-Lin Zhang Zhao-Hui Dong Zhi-Gang Li Xue-Li Zhang Dong Xie Jing-Jing Li Source Type: research

Retraction Note: Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7
Oncogene, Published online: 24 July 2023; doi:10.1038/s41388-023-02786-4Retraction Note: Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7 (Source: Oncogene)
Source: Oncogene - July 24, 2023 Category: Cancer & Oncology Authors: Haiyang Zhang Ting Deng Shaohua Ge Ying Liu Ming Bai Kegan Zhu Qian Fan Jialu Li Tao Ning Fei Tian Hongli Li Wu Sun Guoguang Ying Yi Ba Source Type: research

Correction: A dimerization-dependent mechanism regulates enzymatic activation and nuclear entry of PLK1
Oncogene, Published online: 24 July 2023; doi:10.1038/s41388-023-02779-3Correction: A dimerization-dependent mechanism regulates enzymatic activation and nuclear entry of PLK1 (Source: Oncogene)
Source: Oncogene - July 24, 2023 Category: Cancer & Oncology Authors: Monika Raab Yves Matthess Christopher A. Raab Niklas Gutfreund Volker D ötsch Sven Becker Mourad Sanhaji Klaus Strebhardt Source Type: research

Genetically engineered mouse models of head and neck cancers
Oncogene, Published online: 20 July 2023; doi:10.1038/s41388-023-02783-7Genetically engineered mouse models of head and neck cancers (Source: Oncogene)
Source: Oncogene - July 20, 2023 Category: Cancer & Oncology Authors: Jason Tasoulas Sonal Srivastava Xiaonan Xu Valentina Tarasova Anastasios Maniakas Florian A. Karreth Antonio L. Amelio Source Type: research

Multiple intratumoral sources of kit ligand promote gastrointestinal stromal tumor
Oncogene, Published online: 19 July 2023; doi:10.1038/s41388-023-02777-5Multiple intratumoral sources of kit ligand promote gastrointestinal stromal tumor (Source: Oncogene)
Source: Oncogene - July 19, 2023 Category: Cancer & Oncology Authors: Andrew D. Tieniber Ferdinando Rossi Andrew N. Hanna Marion Liu Mark S. Etherington Jennifer K. Loo Nesteene Param Shan Zeng Kevin Do Laura Wang Ronald P. DeMatteo Source Type: research